Condition
Tauopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Tauopathies clinical trials that are recruiting, at sites in 6 countries (most in United States (4), China (2), Canada (1)). 1 was first registered in the last 30 days. By phase: Early Phase 1 (3), Phase 1/2 (1). The most active sponsors are University of Pennsylvania (4), Tianjin Medical University (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1New in 30 days
- 6Countries
Newest Tauopathies clinical trials
All recruiting trials (9)
-
Tau changes after hip or knee replacement surgery
Researchers will see if brain tau changes after hip or knee surgery and whether these changes relate to inflammation and thinking abilities.
-
Brain PET scan with [18F]NIDF to see tau protein in Alzheimer’s and other tau-related diseases
We are testing whether a new PET tracer called [18F]NIDF can safely show tau protein in the brains of healthy adults and people with Alzheimer’s disease or other tauopathies.
-
ARO-MAPT-SC in healthy adults and people with early Alzheimer's disease
This trial will test whether ARO-MAPT-SC is safe, tolerable, and produces the expected drug levels and biomarker effects in healthy adults and people with early Alzheimer's disease.
-
Investigating a new radiotracer for brain tau protein in neurodegenerative diseases
This study is testing a new imaging tool to see how well it can detect a specific brain protein linked to various neurodegenerative diseases in people who have these conditions and healthy individuals.
-
Evaluating Tau PET/CT for Diagnosing Tau-Related Diseases
This study is testing a new type of imaging scan to see if it can help doctors better diagnose Tau-related diseases in adults with suspected or diagnosed tumors.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
-
Investigating a new radiotracer for brain imaging in Parkinson's disease and related conditions
This study is testing a new brain imaging tool to see if it can help identify abnormal protein deposits in the brains of people with Parkinson's disease and similar conditions.
-
Imaging and diagnostic assessments for tauopathies
This study is testing new brain imaging tools to see if they can help identify different types of brain diseases in people with Parkinson's and other related conditions.
-
Investigating brain uptake of a new radiotracer in tauopathies
This study is testing a new brain imaging tool to see how well it can detect abnormal protein deposits in the brains of people with Multiple System Atrophy, Parkinson's disease, and progressive supranuclear palsy, compared to healthy individuals.
Related topics
Quick answers
How many Tauopathies clinical trials are recruiting right now?
9, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (4 trials), China (2 trials), Canada (1 trial), New Zealand (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.